Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands		Total	Common Stock	Accumulated Deficit	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjustment Accumulated Deficit
Beginning balance (in shares) at Jun. 30, 2017			40,331,645
Beginning balance at Jun. 30, 2017		$ 24,468	$ 245,999	$ (221,531)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of offering costs incurred (in shares)	[1]		15,913,781
Issuance of common stock, net of offering costs incurred	[1]	104,796	$ 104,796
Issuance of common stock as merger consideration (as restated) (in shares)	[2]		3,423,367
Issuance of common stock as merger consideration (as restated)	[2]	23,279	$ 23,279
Stock based compensation (in shares)			374,823
Stock based compensation		1,935	$ 1,935
Excess tax benefit from stock plans		67		67
Retirement of common stock (in shares)	[3]		(44,805)
Retirement of common stock	[3]	(573)	$ (573)
Net loss		(11,284)		(11,284)
Ending balance (in shares) at Jun. 30, 2018			59,998,811
Ending balance at Jun. 30, 2018		142,688	$ 375,436	(232,748)	$ 200	$ 200
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation (in shares)			20,627
Stock based compensation		1,618	$ 1,618
Repurchase of stock option awards		(120)	$ (120)
Retirement of common stock (in shares)			(10,957)
Retirement of common stock		(81)	$ (81)
Net loss		(29,882)		(29,882)
Ending balance (in shares) at Jun. 30, 2019			60,008,481
Ending balance at Jun. 30, 2019		114,423	$ 376,853	(262,430)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of offering costs incurred (in shares)	[1]		3,800,000
Issuance of common stock, net of offering costs incurred	[1]	16,777	$ 16,777
Stock based compensation (in shares)			752,808
Stock based compensation		3,110	$ 3,110
Issuance of common stock to Hudson Executive Capital LP (in shares)	[1]		635,593
Issuance of common stock to Hudson Executive Capital LP	[1]	4,500	$ 4,500
Net loss		(40,595)		(40,595)
Ending balance (in shares) at Jun. 30, 2020			65,196,882
Ending balance at Jun. 30, 2020		$ 98,215	$ 401,240	$ (303,025)

[1] Refer to Note 14 regarding the public offering issued during July 2017 and May 2018, the private placement during October 2019, and the issuance of shares as reimbursement to Hudson Executive Capital LP for costs in connection with its proxy solicitation.

[2] Refer to Note 5 regarding the business acquisition executed during November 2017.

[3] Includes 3,577 shares previously held in escrow in relation to the Cantaloupe acquisition.